ArticleFrontiers in immunology2024

Case report: Diverse immune responses in advanced pancreatic ductal adenocarcinoma treated with immune checkpoint inhibitor-based conversion therapies.

Xiaoying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.